SCHEMBL6273579

SCHEMBL6273579

COC(=O)c1cc(S(=O)(=O)c2ccc(CCN(C[C@@H](O)c3ccccc3)C(=O)OC(C)(C)C)cc2)ccc1O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 5/20 0.41
ADRB3 P13945 4/20 0.38
KDM4E B2RXH2 3/20 0.37
ALDH1A1 P00352 2/20 0.37
MEN1 O00255 1/20 0.37
GAA P10253 1/20 0.37
KMT2A Q03164 1/20 0.37
TAAR1 Q96RJ0 1/20 0.35
ADRB2 P07550 3/20 0.35
ADRB1 P08588 3/20 0.35
CASR P41180 1/20 0.35
ADRA1D P25100 2/20 0.35
ADRA1A P35348 2/20 0.35
ADRA1B P35368 2/20 0.35
HDAC1 Q13547 1/20 0.34
HDAC6 Q9UBN7 1/20 0.34
HPGD P15428 1/20 0.34
EGFR P00533 1/20 0.33
NOX4 Q9NPH5 1/20 0.33
LMNA P02545 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6273575 1.00 BACE1 (0.41) BACE1ADRB3KDM4EALDH1A1MEN1
SCHEMBL6269079 0.92 BACE1 (0.41) BACE1ADRB3KDM4EALDH1A1MEN1
SCHEMBL6269081 0.92 BACE1 (0.41) BACE1ADRB3KDM4EALDH1A1MEN1
SCHEMBL6272978 0.91 KDM4E (0.41) BACE1ADRB3KDM4EALDH1A1GAA
SCHEMBL6273004 0.91 CYP51A1 (0.39) BACE1ADRB3ADRB2ADRB1
SCHEMBL6273006 0.91 CYP51A1 (0.39) BACE1ADRB3ADRB2ADRB1
SCHEMBL6272936 0.84 CYP51A1 (0.39) BACE1ADRB3ADRB2ADRB1
SCHEMBL6272933 0.84 CYP51A1 (0.39) BACE1ADRB3ADRB2ADRB1
SCHEMBL6805832 0.83 BACE1 (0.39) BACE1ADRB3ADRB2ADRB1
SCHEMBL6805827 0.83 BACE1 (0.39) BACE1ADRB3ADRB2ADRB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005110981-A1 AMINOALCOHOL DERIVATIVES ASTELLAS PHARMA INC. (JP) 2005-11-24 WO disclosed
US-20040106653-A1 Aminoalcohol derivatives FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-06-03 US disclosed
WO-2004045610-A1 AMINOALCOHOL DERIVATIVES AND THEIR USE AS BETA-3 ADRENERGIC RECEPTOR AGONISTS FUJISAWA PHARMACEUTICAL CO., LTD (JP) 2004-06-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040106653-A1 Aminoalcohol derivatives FANCD2, FANCI, HRH2 BACE1 4413/4885ADRB3 150/4885KDM4E 994/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.